ロード中...
Tenofovir is superior to entecavir for achieving complete viral suppression in hbeag-positive chronic hepatitis b patients with high hbv dna
BACKGROUND: Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are the two first-line antiviral therapies for chronic hepatitis B (CHB); however, there are limited studies directly comparing their effectiveness. AIMS: To compare the effectiveness of ETV and TDF in nucleos(t)-ide-naïve CHB patie...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3999385/ https://ncbi.nlm.nih.gov/pubmed/24467455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.12629 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|